Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-21

Clinical Trial Update: Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of a d-amphetamine transdermal system versus placebo in children and adolescents with ADHD has completed; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • d-Amphetamine Transdermal System (d-amphetamine transdermal system)

Snippet

Sponsor: Noven Pharmaceuticals, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-12-21